|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net (loss) income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation, depletion and amortization | |||||
| (Benefit) provision for deferred income taxes | |||||
| Loss on extinguishment of debt | |||||
| Stock-based compensation | |||||
| Gain on property insurance proceeds | |||||
| Derivative mark-to-market adjustments and settlements | |||||
| Net loss on disposal of assets | |||||
| (Decrease) increase in earn-out liability | |||||
| Accretion of asset retirement obligations | |||||
| Liabilities associated with properties sold | |||||
| Amortization of debt issuance costs | |||||
| Impairment loss | |||||
| Non cash expense - RINs sold from equity method investment | |||||
| Income from equity method investment | |||||
| Accounts receivable | |||||
| Royalty offset long term receivable | |||||
| Income tax receivable | |||||
| Critical spare inventory | |||||
| Accounts payable and Accrued liabilities | |||||
| Other | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Asset acquisition | |||||
| Capital contributions to equity method investments | |||||
| Cash collateral deposits | |||||
| Proceeds from insurance recovery | |||||
| Proceeds from sale of assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Repayments of long-term debt | |||||
| Debt issuance costs | |||||
| Debt extinguishment costs | |||||
| Borrowings on revolver | |||||
| Repayments on revolver | |||||
| Contingent consideration payments | |||||
| Common stock issuance | |||||
| Treasury stock purchase | |||||
| Related party receivable | |||||
| Finance lease payments | |||||
| Net cash provided (used) in financing activities | |||||
| Net decrease in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash at beginning of period | |||||
| Cash and cash equivalents and restricted cash at end of period | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest, net of $1,308 and $0 capitalized respectively | |||||
| Cash paid for income taxes | |||||
| Accrual for purchase of property, plant and equipment included in accounts payable and accrued liabilities | |||||
| Non-cash purchase of Treasury stock | |||||
| Non-cash RIN distribution from equity method investment | |||||
| Reconciliation of cash, cash equivalents, and restricted cash at end of period: | |||||
| Cash and cash equivalents | |||||
| Restricted cash and cash equivalents - current | |||||
| Restricted cash and cash equivalents - non-current | |||||
Loading...